Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats

Published:2022-02 Issue: Volume:231 Page:109261
ISSN:0376-8716
Container-title:Drug and Alcohol Dependence
language:en
Short-container-title:Drug and Alcohol Dependence

Author:

Synan Colleen,Bowen Carrie,Heal David J.,Froger-Colléaux Christelle,Beardsley Patrick M.,Dedic Nina,Hopkins Seth C.,Campbell Una,Koblan Kenneth S.

Funder

Sunovion Pharmaceuticals Inc

Publisher

Elsevier BV

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology

Reference51 articles.

1. Interaction Between the Trace Amine-Associated Receptor 1 and the Dopamine D2 Receptor Controls Cocaine’s Neurochemical Actions;Asif-Malik;Sci. Rep.,2017

2. Time-course analysis of the discriminative stimulus effects of the optical isomers of 3,4-methylenedioxymethamphetamine (MDMA);Baker;Pharmacol. Biochem. Behav.,1997

3. Abuse potential of buspirone and related drugs;Balster;J. Clin. Psychopharmacol.,1990

4. Towards Novel Treatments for Schizophrenia: Molecular and Behavioural Signatures of the Psychotropic Agent SEP-363856;Begni;Int. J. Mol. Sci.,2021

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TAARs as Novel Therapeutic Targets for the Treatment of Depression: A Narrative Review of the Interconnection with Monoamines and Adult Neurogenesis;Biomedicines;2024-06-06

2. Schizophrenia interactome derived repurposable drugs and randomized control trials of two candidates;Biological Psychiatry;2024-06

3. TAAR1 as an emerging target for the treatment of psychiatric disorders;Pharmacology & Therapeutics;2024-01

4. A Phase I, Open-Label, Fixed Sequence Study to Investigate the Effect of Cytochrome P450 2D6 Inhibition on the Pharmacokinetics of Ulotaront in Healthy Subjects;Clinical Pharmacokinetics;2023-10-26

5. Novo tratamento para esquizofrenia baseado em agonista de TAAR 1;Cuadernos de Educación y Desarrollo;2023-10-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3